Clinical tools to identify individuals with unstable atherosclerotic lesions are required to improve prevention of myocardial infarction and ischemic stroke. Here, a systems-based analysis of atherosclerotic plaques and plasma from patients undergoing carotid endarterectomy for stroke prevention was used to identify molecular signatures with a causal relationship to disease. Local plasma collected in the lesion proximity following clamping prior to arteriotomy was profiled together with matched peripheral plasma. This translational workflow identified biliverdin reductase B as a novel marker of intraplaque hemorrhage and unstable carotid atherosclerosis, which should be investigated as a potential predictive biomarker for cardiovascular eve...
Background: Blood-based biomarkers of atherosclerosis have been used to identify patients at high ri...
Objective-Atherosclerotic cardiovascular disease is a major burden to health care. Because atheroscl...
Molecular characterisation of vulnerable atherosclerosis is necessary for targeting functional imagi...
Clinical tools to identify individuals with unstable atherosclerotic lesions are required to improve...
Background: Intraplaque hemorrhage (IPH) is a hallmark of atherosclerotic plaque instability. Bilive...
Background While single-omics analyses on human atherosclerotic plaque have been very useful to map ...
Cardiovascular disease (CVD) as result of atherosclerosis is a major cause of morbidity and mortalit...
BACKGROUND: The identification of patients with high-risk atherosclerotic plaques prior to the manif...
Carotid plaque stenosis is responsible of 15-20% of all ischemic strokes; despite that, asymptomatic...
BACKGROUND. The identification of patients with high-risk atherosclerotic plaques prior to the manif...
Objective: Atherosclerosis is an inflammatory process that results in complex lesions or plaques tha...
Background: Blood-based biomarkers of atherosclerosis have been used to identify patients at high ri...
Objective-Atherosclerotic cardiovascular disease is a major burden to health care. Because atheroscl...
Molecular characterisation of vulnerable atherosclerosis is necessary for targeting functional imagi...
Clinical tools to identify individuals with unstable atherosclerotic lesions are required to improve...
Background: Intraplaque hemorrhage (IPH) is a hallmark of atherosclerotic plaque instability. Bilive...
Background While single-omics analyses on human atherosclerotic plaque have been very useful to map ...
Cardiovascular disease (CVD) as result of atherosclerosis is a major cause of morbidity and mortalit...
BACKGROUND: The identification of patients with high-risk atherosclerotic plaques prior to the manif...
Carotid plaque stenosis is responsible of 15-20% of all ischemic strokes; despite that, asymptomatic...
BACKGROUND. The identification of patients with high-risk atherosclerotic plaques prior to the manif...
Objective: Atherosclerosis is an inflammatory process that results in complex lesions or plaques tha...
Background: Blood-based biomarkers of atherosclerosis have been used to identify patients at high ri...
Objective-Atherosclerotic cardiovascular disease is a major burden to health care. Because atheroscl...
Molecular characterisation of vulnerable atherosclerosis is necessary for targeting functional imagi...